Accumulation activities seems continuing on the counter. Last trading day saw price up 8% with significant volume. Current price is consolidating within 0.3 to 0.34. It would be interesting to see whether buyer could pull it from the narrow zone for next record high over past five years.
*** Note: Same counter has been mentioned in Chart[24] @ 2016 ***
Saturday, September 24, 2016
Sep[8] - Market Updates
Crude Oil:
Oil price has been bouncing within a descending triangle over past one month as below. Opec members shall meet non Opec member, Russia on 28 Sep. The decision from meeting might decide which direction shall price break out from the consolidation zone.
Singapore:
Market generally cheered with dovish stance from US Federal Reserve. STI moved up on last week, but capped with down sliding resistance line. Price shall break up 2900 to show some up moving strength.
Market Calendar on coming week:
(SG: Singapore; CH: China; UK: United Kingdom; US: USA)
Oil price has been bouncing within a descending triangle over past one month as below. Opec members shall meet non Opec member, Russia on 28 Sep. The decision from meeting might decide which direction shall price break out from the consolidation zone.
Singapore:
Market generally cheered with dovish stance from US Federal Reserve. STI moved up on last week, but capped with down sliding resistance line. Price shall break up 2900 to show some up moving strength.
Market Calendar on coming week:
(SG: Singapore; CH: China; UK: United Kingdom; US: USA)
Sep[7] - Tianjin ZX USD (Attractive Discount)
COUNTER: Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
OVERVIEW:
The company produces and sells traditional Chinese medicines (TCM, which is its core business), western medicines and healthcare products primarily in China. It has a complete industrial chain, product chain around its core business. Some of its units which engage in chemical drug, bio-medicine are operated jointly with world famous pharmaceutical giants like GlaxoSmithKline.
With its product variety, 4 have been honored as National Treasure like creation; 10 are stated protected Chinese medicines, 67 listed in National Basic Medicine Catalog, 267 are available in national medicine insurance service system. It has one state-level enterprise technology center, five municipality-level enterprise technology engineering center on China. It was listed in SGX on 1997 and on Shanghai Exchange on 2001.
HIGHLIGHTS:
[1] Its latest result registered 1H2016 revenue and profit at RMB3.2b and RMB288m, which maintained year on year. Its income has been very stable over past 4 years.
[2] On April 2016, HK Department of Heath announced that one batch of TCM tablets from the counter containing traces of Western drug which is not listed in its authorized prescription. Relevant product was recalled from HK and production ceased thereafter. Investigation ended on June, the factory has resumed and relevant certifications was reinstated.
[3] It's in net cash position, since cash on hold can fully meet debts.
INVESTMENT THEMES:
[1] Current S-shares (listed in SG) valuation:
Book value - USD0.79 || Earning per share (1H2016) - USD0.051 || Dividend (2016) - SGD0.031
At shares price USD0.75, it translates to P/B ~ 0.95, P/E ~ 7.5, Dividend yield ~ 3%
[2] Its A-shares price (listed in Shanghai) is generally valued at P/B > 3, PE > 20.
By comparison, its shares price in SG looks over-discounted. Considering recent de-listing activities in domestic market, it would be hard not to speculate when the counter becomes next candidate.
[3] The counter shares is denominated in USD. Recent exchange rate of USD-SGD hovers at its one year bottom. The falling of exchange rate coincided with price weakening moment of the cash rich counter. The timing looks just perfect.
PRICE TREND:
The counter's S-shares actually rebounded from its three years support ~ USD0.73.
It's A-shares price movement as below. Difference price trend shown.
OVERVIEW:
The company produces and sells traditional Chinese medicines (TCM, which is its core business), western medicines and healthcare products primarily in China. It has a complete industrial chain, product chain around its core business. Some of its units which engage in chemical drug, bio-medicine are operated jointly with world famous pharmaceutical giants like GlaxoSmithKline.
With its product variety, 4 have been honored as National Treasure like creation; 10 are stated protected Chinese medicines, 67 listed in National Basic Medicine Catalog, 267 are available in national medicine insurance service system. It has one state-level enterprise technology center, five municipality-level enterprise technology engineering center on China. It was listed in SGX on 1997 and on Shanghai Exchange on 2001.
[1] Its latest result registered 1H2016 revenue and profit at RMB3.2b and RMB288m, which maintained year on year. Its income has been very stable over past 4 years.
[2] On April 2016, HK Department of Heath announced that one batch of TCM tablets from the counter containing traces of Western drug which is not listed in its authorized prescription. Relevant product was recalled from HK and production ceased thereafter. Investigation ended on June, the factory has resumed and relevant certifications was reinstated.
[3] It's in net cash position, since cash on hold can fully meet debts.
INVESTMENT THEMES:
[1] Current S-shares (listed in SG) valuation:
Book value - USD0.79 || Earning per share (1H2016) - USD0.051 || Dividend (2016) - SGD0.031
At shares price USD0.75, it translates to P/B ~ 0.95, P/E ~ 7.5, Dividend yield ~ 3%
[2] Its A-shares price (listed in Shanghai) is generally valued at P/B > 3, PE > 20.
By comparison, its shares price in SG looks over-discounted. Considering recent de-listing activities in domestic market, it would be hard not to speculate when the counter becomes next candidate.
[3] The counter shares is denominated in USD. Recent exchange rate of USD-SGD hovers at its one year bottom. The falling of exchange rate coincided with price weakening moment of the cash rich counter. The timing looks just perfect.
PRICE TREND:
The counter's S-shares actually rebounded from its three years support ~ USD0.73.
It's A-shares price movement as below. Difference price trend shown.
Saturday, September 17, 2016
Sep[6] - Market Updates
US:
After two months of deep sleep, Dow Jones woke up with emerging selling pressure. Ahead of FOMC meeting on coming week, it swung drastically in 400 points. Rate hike used to be time bomb to securities market. Immediate support ~ 18022. Local market is expected to react accordingly as well.
Crude Oil:
Besides rate hike worries, weakening oil price is another factor which pressurizes market. Immediate support ~ USD43, followed by USD40.
Market Calendar on coming week:
(SG: Singapore; CH: China; UK: United Kingdom; US: USA)
After two months of deep sleep, Dow Jones woke up with emerging selling pressure. Ahead of FOMC meeting on coming week, it swung drastically in 400 points. Rate hike used to be time bomb to securities market. Immediate support ~ 18022. Local market is expected to react accordingly as well.
Crude Oil:
Besides rate hike worries, weakening oil price is another factor which pressurizes market. Immediate support ~ USD43, followed by USD40.
Market Calendar on coming week:
(SG: Singapore; CH: China; UK: United Kingdom; US: USA)
Friday, September 16, 2016
Sep[5] - ComfortDelgro (Buy on dip)
COUNTER: ComfortDelgro Corporation Limited
OVERVIEW:
The counter is the world's second largest listed land transport companies with total flee size of over 46650 buses, taxis and rental vehicles. Business segments include bus, taxi, rail, car rental and leasing, automotive servicing, driving centers. Operation exists in 7 countries: SG, Aus, China, UK, Ireland, Vietnam and Malaysia.
HIGHLIGHTS:
[1] Its latest results saw 1H2016 registered 1% and 5% growth in revenue and net profit year on year. Earning contribution is well diversified across few countries:
[2] The counter is in net cash position of $323m. Total debt/equity is as low as ~15%.
INVESTMENT THEMES:
[1] Current valuation looks attractive:
Earning per share (1H2016) - 0.073 || Dividend (2016) - 0.0925 || Dividend growth > 8% pa
[2] Under new bus operating regime, LTA will own all operating assets from SBS (75% own by the counter) and SMRT. Instead of paying a lump sum, LTA pays leasing charge to operators up based on bus packages contract ranging from 2 to 10 years. Over the entire contracts, SBS will be paid $5.3b. This could translate to progressive improvement on balance sheets of the counter.
[3] Ridership on North East Line and Downtown Line (DTL) is picking up. 3rd section of DTL is target for completion on 2017.
[4] Shall SMRT to be privatized, the counter will be the sole representative from public transport sector in local exchange. It might draw further attention due to its defensive business nature.
PRICE TREND:
The counter showed its resilience throughout various market panicking moment (devaluation RMB, rate hike worries, BREXIT) over past 1 year. Strong support ~ 2.64. Recent market turbulence provided hunting period to it again.
*** Note: Same counter has been mentioned in May[8] 2016 ***
OVERVIEW:
The counter is the world's second largest listed land transport companies with total flee size of over 46650 buses, taxis and rental vehicles. Business segments include bus, taxi, rail, car rental and leasing, automotive servicing, driving centers. Operation exists in 7 countries: SG, Aus, China, UK, Ireland, Vietnam and Malaysia.
HIGHLIGHTS:
[1] Its latest results saw 1H2016 registered 1% and 5% growth in revenue and net profit year on year. Earning contribution is well diversified across few countries:
INVESTMENT THEMES:
[1] Current valuation looks attractive:
Earning per share (1H2016) - 0.073 || Dividend (2016) - 0.0925 || Dividend growth > 8% pa
[2] Under new bus operating regime, LTA will own all operating assets from SBS (75% own by the counter) and SMRT. Instead of paying a lump sum, LTA pays leasing charge to operators up based on bus packages contract ranging from 2 to 10 years. Over the entire contracts, SBS will be paid $5.3b. This could translate to progressive improvement on balance sheets of the counter.
[3] Ridership on North East Line and Downtown Line (DTL) is picking up. 3rd section of DTL is target for completion on 2017.
[4] Shall SMRT to be privatized, the counter will be the sole representative from public transport sector in local exchange. It might draw further attention due to its defensive business nature.
PRICE TREND:
The counter showed its resilience throughout various market panicking moment (devaluation RMB, rate hike worries, BREXIT) over past 1 year. Strong support ~ 2.64. Recent market turbulence provided hunting period to it again.
*** Note: Same counter has been mentioned in May[8] 2016 ***
Sunday, September 11, 2016
Chart[24] - Small counters with big interests
Significant buying volume was seen in following counters. Trader could take position for next potential push from hidden buyers.
Avi-Tech
Fu Yu
Singmedical
Avi-Tech
Fu Yu
Singmedical
Friday, September 9, 2016
Sep[4] - Market Updates
US:
On last trading day alone, Dow Jones shed 2%. Rate hike fear could be haunting market again. Two important meetings for this month: US FOMC [20th Sep] and OPEC energy conference [26-28th].
Market Calendar on coming week:
(SG: Singapore; CH: China; UK: United Kingdom; US: USA)
On last trading day alone, Dow Jones shed 2%. Rate hike fear could be haunting market again. Two important meetings for this month: US FOMC [20th Sep] and OPEC energy conference [26-28th].
Market Calendar on coming week:
(SG: Singapore; CH: China; UK: United Kingdom; US: USA)
Sep[3] - Dutech (Put money in Safes!)
COUNTER: Dutech Holdings Limited
OVERVIEW:
The counter is a global leading manufacturer in the high security equipment industry. As a leading Original Design Manufacturer (ODM) and largest producer in Asia, it supplies wide range of high security products such as ATM safes, bank safes, commercial safes, and cash handling systems for both commercial and consumer uses. Its headquarter is located in Shanghai, which serves as center of research & development. The reputable global customers base consists of Wincor Nixdorf (World No 2 ATM maker), Hitachi, Liberty Safe & Security Products, etc.
HIGHLIGHTS:
[1] The past five years saw its earning growing steadily. Its market base is well diversified into Europe, US and China.
[2] Latest quarter result saw both revenue and profit leap ~ 20%, due to recent acquisition of Krauth (developer of Auto-Ticketing Machine and Money Changers) from Germany. It enhanced contribution to business solution segment.
[3] It is in net cash position of RMB200m which is mainly held in USD, thus reducing the exposure to weakening RMB.
INVESTMENT THEMES:
[1] Its 1H2016 earning per shares is RMB0.15, so last trading price (0.485) translates to P/E ~ 8, dividend yield ~ 2%.
[2] Over past four years, the group managed to deliver high ROE and ROA ~ 10% consistently, which showed strong management and execution on delivering results.
[3] Until 2020, Asia Pacific and global vending machine market is forecast to grow >10% annually. The group is working towards vertical integration and move up the value chain so as to provide one-stop solutions for worldwide clients in future.
PRICE TREND:
The counter has been delivering strong earning results over past two quarters. Strong buying interest was seen on days following the result as well. It's highlighted in June and Aug period below. Uptrend is residing above 0.465. Investor could take position now so as to enjoy potential push from big player next round.
*** Note: Same counter has been mentioned in Chart[22] 2016 ***
OVERVIEW:
The counter is a global leading manufacturer in the high security equipment industry. As a leading Original Design Manufacturer (ODM) and largest producer in Asia, it supplies wide range of high security products such as ATM safes, bank safes, commercial safes, and cash handling systems for both commercial and consumer uses. Its headquarter is located in Shanghai, which serves as center of research & development. The reputable global customers base consists of Wincor Nixdorf (World No 2 ATM maker), Hitachi, Liberty Safe & Security Products, etc.
HIGHLIGHTS:
[1] The past five years saw its earning growing steadily. Its market base is well diversified into Europe, US and China.
[2] Latest quarter result saw both revenue and profit leap ~ 20%, due to recent acquisition of Krauth (developer of Auto-Ticketing Machine and Money Changers) from Germany. It enhanced contribution to business solution segment.
[3] It is in net cash position of RMB200m which is mainly held in USD, thus reducing the exposure to weakening RMB.
INVESTMENT THEMES:
[1] Its 1H2016 earning per shares is RMB0.15, so last trading price (0.485) translates to P/E ~ 8, dividend yield ~ 2%.
[2] Over past four years, the group managed to deliver high ROE and ROA ~ 10% consistently, which showed strong management and execution on delivering results.
[3] Until 2020, Asia Pacific and global vending machine market is forecast to grow >10% annually. The group is working towards vertical integration and move up the value chain so as to provide one-stop solutions for worldwide clients in future.
PRICE TREND:
The counter has been delivering strong earning results over past two quarters. Strong buying interest was seen on days following the result as well. It's highlighted in June and Aug period below. Uptrend is residing above 0.465. Investor could take position now so as to enjoy potential push from big player next round.
*** Note: Same counter has been mentioned in Chart[22] 2016 ***
Sunday, September 4, 2016
Chart[23] - Cogent
The counter saw surging volume on last few trading days. A triple top break up at 0.705 with significant transaction volume. Looking backwards, similar break up happened at 0.535 on May, 0.58 on early July and 0.66 on late July. The counter could be heading next record high in continuation of current uptrend.
Saturday, September 3, 2016
Sep[2] - Market Updates
Singapore:
STI ended last week amid worries of potential rate hike in coming Fed meeting. Last trading day the index breaking down support 2809 following plummeting of SingTel and Starhub. Immediate support is ~ 2700. Investor could accumulate STI ETF shall STI approaching 2700. OPEC Russia meeting and FOMC shall be major market theme on September.
Market Calendar on coming week:
(SG: Singapore; CH: China; UK: United Kingdom; US: USA)
STI ended last week amid worries of potential rate hike in coming Fed meeting. Last trading day the index breaking down support 2809 following plummeting of SingTel and Starhub. Immediate support is ~ 2700. Investor could accumulate STI ETF shall STI approaching 2700. OPEC Russia meeting and FOMC shall be major market theme on September.
Market Calendar on coming week:
(SG: Singapore; CH: China; UK: United Kingdom; US: USA)
Friday, September 2, 2016
Sep[1] - SingTel (Welcome 4th Telco)
COUNTER: Singapore Telecommunications Limited
OVERVIEW:
The counter is a leading communication group with significant presence in Singapore and Australia (Optus). It own stakes in regional mobile associates, namely Bharti Airtel (India, South Asia and Africa), Telkomsel (Indonesia), Advanced Info Service (Thailand) and Globe Telecom (the Philippines). The services range include fixed line, mobile, data, internet, TV, infocomm technology (ICT) and digital solutions.
HIGHLIGHTS:
[1] The latest result saw its earning growing steadily. Shrinking domestic earning offset by overseas contribution.
[2] The group is in net debt position, $7.9b. Total debt/equity < 40%, which is lowest among local telcos.
[3] Three parties submitted application to be 4th telco by deadline, 1 Sep. IDA is expected to make decision in end Sep ~ early October.
INVESTMENT THEMES:
[1] Its annual dividend is $0.170. Shall price fall below 4, dividend yield is attractive at 4.2%
[2] Mobile business in Singapore contributes ~7% of total revenue of the group. Thus it should be the least susceptible to impact from 4th telco.
[3] The group continues to raise its shareholding in regional telco group.
PRICE TREND:
The defensive counter has cyclic behavior in its price movement over past three years. A simple average price is $ 3.9. Current price is trading in the lower zone. Accumulate chance is presenting.
*** Note: Same counter has been mentioned in Sep[2] 2015 ***
OVERVIEW:
The counter is a leading communication group with significant presence in Singapore and Australia (Optus). It own stakes in regional mobile associates, namely Bharti Airtel (India, South Asia and Africa), Telkomsel (Indonesia), Advanced Info Service (Thailand) and Globe Telecom (the Philippines). The services range include fixed line, mobile, data, internet, TV, infocomm technology (ICT) and digital solutions.
HIGHLIGHTS:
[1] The latest result saw its earning growing steadily. Shrinking domestic earning offset by overseas contribution.
[2] The group is in net debt position, $7.9b. Total debt/equity < 40%, which is lowest among local telcos.
[3] Three parties submitted application to be 4th telco by deadline, 1 Sep. IDA is expected to make decision in end Sep ~ early October.
INVESTMENT THEMES:
[1] Its annual dividend is $0.170. Shall price fall below 4, dividend yield is attractive at 4.2%
[2] Mobile business in Singapore contributes ~7% of total revenue of the group. Thus it should be the least susceptible to impact from 4th telco.
[3] The group continues to raise its shareholding in regional telco group.
PRICE TREND:
The defensive counter has cyclic behavior in its price movement over past three years. A simple average price is $ 3.9. Current price is trading in the lower zone. Accumulate chance is presenting.
*** Note: Same counter has been mentioned in Sep[2] 2015 ***
Subscribe to:
Posts (Atom)